MoonLake Immunotherapeutics (NASDAQ:MLTX) Earns Buy Rating from Needham & Company LLC
Needham & Company LLC reiterated their buy rating on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in a research note released on Wednesday morning,Benzinga reports. Needham & Company LLC currently has a $66.00 target price on the stock. Other research analysts have also recently issued reports about the stock. Royal Bank of Canada initiated […]
Needham & Company LLC reiterated their buy rating on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in a research note released on Wednesday morning,Benzinga reports. Needham & Company LLC currently has a $66.00 target price on the stock. Other research analysts have also recently issued reports about the stock. Royal Bank of Canada initiated […]
